The platform trial in COVID-19 priming and BOOsting (PICOBOO): The reactogenicity of nine licensed COVID-19 vaccines delivered in immunocompetent adults
McLeod C, Dymock, K.L. Flanagan, M. Plebanski et autres
0 citationsVaccine
R B Thornton
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
5Publications signalées
6Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
SARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinationsvaccines and immunoinformatics approachesVaccine Coverage and HesitancyLong-Term Effects of COVID-19
Publications récentes
The Platform trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity and safety of seven licensed COVID-19 vaccines delivered as fifth dose or subsequent boosters in immunocompetent adults
McLeod C., Dymock, K.L. Flanagan, M. Plebanski et autres
0 citationsVaccine
The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-<50 and 50-<70 years old
Michael Dymock, Katie L. Flanagan, Magdalena Plebanski, Helen Marshall et autres
1 citationJournal of Infection
The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years old
Dymock, Katie L. Flanagan, Magdalena Plebanski, Helen Marshall et autres
5 citationsJournal of Infection
パネル7-中耳炎の病因-2015年と2019年の文献レビュー【JST・京大機械翻訳】
R B Thornton, and Hakan Hakansson, D W Hood, J Nokso-Koivisto et autres
0 citationsInternational Journal of Pediatric Otorhinolaryngology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.